Related Experiment Video

Updated: Feb 15, 2026

A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease
07:17

A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease

Published on: January 29, 2021

6.6K

Using drugs to target necroptosis: dual roles in disease therapy

Zhen Wang1, Li-Min Guo1, Hong-Kang Zhou1

  • 1Department of Anatomy and Neurobiology, School of Basic Medical Sciences, Central South University, Changsha, Hunan, China.

Histology and Histopathology
|February 3, 2018
PubMed

Insights

Necroptosis, a programmed cell death, is regulated by the RIP1-RIP3-MLKL pathway. Understanding its role in diseases like cancer and neurodegeneration offers hope for new drug therapies.

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Pathology

Background:

  • Necroptosis is a regulated form of necrosis with a decade of research.
  • The RIP1-RIP3-MLKL axis is the primary mechanism governing necroptotic cell death.
  • Both positive (HSP90, TAK1) and negative (caspase 8, c-FLIP) regulators of necroptosis are well-defined.

Purpose of the Study:

  • To review current understanding of necroptosis.
  • To explore the involvement of necroptosis in various diseases.
  • To discuss potential therapeutic strategies targeting necroptosis.

Main Methods:

  • Literature review of necroptosis mechanisms.
  • Analysis of necroptosis's role in disease pathogenesis.
  • Identification of potential drug targets for necroptosis modulation.

Main Results:

  • Established knowledge of necroptosis regulatory pathways.
  • Identified links between necroptosis and diseases including ischemia, neurodegeneration, infection, and cancer.
  • Highlighted the therapeutic potential of modulating necroptosis.

Conclusions:

  • Necroptosis is a key cellular process implicated in diverse pathologies.
  • Targeting necroptosis presents promising therapeutic avenues for various diseases.
  • Further research into necroptosis mechanisms and drug development is warranted.

More Related Videos

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis08:55

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis

Published on: August 7, 2018

11.3K
ALS - Motor Neuron Disease: Mechanism and Development of New Therapies15:48

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

10.1K

Related Concept Videos

Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
310
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Hepatic Drug Clearance: Role of Transporters01:14

Hepatic Drug Clearance: Role of Transporters

In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
313
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.6K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
8
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.5K